Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CONNECTICUT "DEFINITION OF DRUG DOSAGE FORMS" ACT WOULD PROHIBIT PHARMACIST SUBSTITUTION OF "UNIQUE DELIVERY SYSTEM" DRUGS; CALIF. CONSIDERS SIMILAR BILL

Executive Summary

A Connecticut Act "Concerning the Definition of Drug Dosage Forms" would prohibit a pharmacist from substituting any drug or product if the originally prescribed product utilizes a "unique delivery system technology." Governor Weicker (Ind.) received the bill May 2 after it passed both Houses of the state legislature; a signature was required by May 7 for it to become law. The Connecticut bill is modeled after an Oregon bill that became law last year.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS024433

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel